Analysis of 74 CAR-T therapy patients inform a Blue + Prime future
Since the launch of two CAR-T therapies in 2017, we’re hitting the cell and gene therapy learning curve with everything we’ve got. Read more
News from Prime
MedDrive to harness the multi-billion-dollar potential savings in biosimilar market.
Award highlights Prime’s commitment to inclusion.
Prime makes list in 2021 for the third time, in part due to its employee engagement initiatives.
Prime in the news
Prime Rolls Out New Medical Benefit Management Offering
AIS’s Radar on Specialty Pharmacy
Gene therapy doesn't have to break the bank
Specialty Pharmacy Continuum
People on the Move: David Schlett
Get in touch
Connect with one of our media experts to learn more about the latest news and trends in the pharmacy benefit management industry.